REFERENCES
- Isner J M. Myocardial gene therapy. Nature 2002; 415: 234–239, [PUBMED], [INFOTRIEVE], [CSA]
- Vale P R, Losordo D W, Milliken C E, McDonald M C, Gravelin L M, Curry C M, Esakof D D, Maysky M, Symes J F, Isner J M. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 2001; 103: 2138–2143, [PUBMED], [INFOTRIEVE], [CSA]
- Kastrup J, Jørgensen E, Drvota V. Vascular growth factor and gene therapy to induce new vessels in the ischemic myocardium: therapeutic angiogenesis. Scand Cardiovas J 2001; 35: 291–296, [CSA], [CROSSREF]
- Losordo D W, Vale P R, Hendel R C, Milliken C E, Fortuin F D, Cummings N, Schatz R A, Asahara T, Isner J M, Kuntz R E. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002; 105: 2012–2018, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kastrup J. Therapeutic angiogenesis in ischemic heart disease: gene or recombinant vascular growth factor therapy?. Current Gene Therapy 2003; 3: 197–206, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kastrup J, Jørgensen E, Drvota V, Thuesen L, Bøtker H E, Gyöngyösi M, Glogar D, Rück A, Islam K B, Sylvén C, The Euroinject One group. Intramyocardial injection of genes by a novel percutaneous technique: initial safety data in the Euroinject One study. Heart/Drug 2001; 1: 299–304, [CSA]
- Grines C L, Watkins M W, Helmer G, Penny W, Brinker J, Marmur J D, West A, Rade J J, Marrott P, Hammond H K, Engler R L. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002; 105: 1291–1297, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Simons M, Annex B H, Laham R J, Kleiman N, Henry T, Dauerman H, Udelson J E, Gervino E V, Pike M, Whitehouse M J, Moon T, Chronos N A. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 2002; 105: 788–793, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Henry T D, Annex B H, McKendall G R, Azrin M A, Lopez J J, Giordano F J, Shah P K, Willerson J T, Benza R L, Berman D S, Gibson C M, Bajamonde A, Rundle A C, Fine J, McCluskey E R, VIVA Investigators. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 2003; 107: 1359–1365, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kastrup J E, Joergensen A, Rück K, Tägil D, Glogar M, Gyöngyösi W, Ruzyllo H E, Bøtker D, Dudek V, Drvota B, Hesse L, Thuesen P, Blomberg C, Sylvén, for the Euroinject One Group. Direct intramyocardial injection of the VEGF-A165 gene in severe chronic ischemic heart disease—a double-blind placebo-controlled study: The Euroinject One Trial. J Am Coll Cardiol 2005; 45: 982–988, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner J M. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964–3972, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Van Gelder R N, von Zastrow M E, Yool A, Dement W C, Barchas J D, Eberwine J H. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci USA 1990; 87: 1663–1667, [PUBMED], [INFOTRIEVE], [CSA]
- Scheidl S J, Nilsson S, Kalen M, Hellstrom M, Takemoto M, Hakansson J, Lindahl P. mRNA expression profiling of laser microbeam microdissected cells from slender embryonic structures. Am J Pathol 2002; 160: 801–813, [PUBMED], [INFOTRIEVE], [CSA]
- Lee S H, Wolf P L, Escudero R, Deutsch R, Jamieson S W, Thistlethwaite P A. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000; 342: 626–633, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sasaki H, Fukuda S, Otani H, Zhu L, Yamaura G, Engelman R M, Das D K, Maulik N. Hypoxic preconditioning triggers myocardial angiogenesis: a novel approach to enhance contractile functional reserve in rat with myocardial infarction. J Mol Cell Cardiol 2002; 34: 335–348, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shizukuda Y, Iwamoto T, Mallet R T, Downey H F. Hypoxic preconditioning attenuates stunning caused by repeated coronary artery occlusions in dog heart. Cardiovasc Res 1993; 127: 559–564, [CSA]
- Li J, Brown L F, Hibberd M G, Grossman J D, Morgan J P, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 1996; 270: H1803–H1811, [PUBMED], [INFOTRIEVE], [CSA]
- Miraliakbari R, Francalancia N A, Lust R M, Gerardo J A, Ng P C, Sun Y S, Chitwood W R, Jr. Differences in myocardial and peripheral VEGF and KDR levels after acute ischemia. Ann Thorac Surg 2000; 69: 1750–1754, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ladoux A, Frelin C. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 1993; 195: 1005–1010, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Aparicio S, Sawant S, Lara N, Barnstable C J, Tombran-Tink J. Expression of angiogenesis factors in human umbilical vein endothelial cells and their regulation by PEDF. Biochem Biophys Res Commun 2005; 326: 387–394, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gu W, Brannstrom T, Jiang W, Bergh A, Wester P. Vascular endothelial growth factor-A and -C protein up-regulation and early angiogenesis in a rat photothrombotic ring stroke model with spontaneous reperfusion. Acta Neuropathol 2001; 102: 216–226, [PUBMED], [INFOTRIEVE], [CSA]
- Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M, Principe N, Kearney M, Hu J S, Isner J M. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 1998; 153: 381–394, [PUBMED], [INFOTRIEVE], [CSA]
- Chou E, Suzuma I, Way K J, Opland D, Clermont A C, Naruse K, Suzuma K, Bowling N L, Vlahos C J, Aiello L P, King G L. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002; 105: 373–379, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ruck A, Gustafsson T, Norrbom J, Nowak J, Kallner G, Soderberg M, Sylven C, Drvota V. ANP and BNP but not VEGF are regionally overexpressed in ischemic human myocardium. Biochem Biophys Res Commun 2004; 322: 287–291, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Goetze J P, Gore A, Moller C H, Steinbruchel D A, Rehfeld J F, Nielsen L B. Acute myocardial hypoxia increases BNP gene expression. FASEB J 2004; 18: 1928–1930, [PUBMED], [INFOTRIEVE], [CSA]
- Braunwald E, Kloner R A. Myocardial reperfusion: a double edged sword. J Clin Invest 1985; 76: 1713–1719, [PUBMED], [INFOTRIEVE], [CSA]
- Banai S., Shweiki D., Pinson A., Chandra M., Lazarovici G., Keshet E. Up-regulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 1994; 28: 1176–1179, [PUBMED], [INFOTRIEVE], [CSA]
- Cotton J M, Mathur A, Hong Y, Brown A S, Martin J F, Erusalimsky J D. Acute rise of circulating vascular endothelial growth factor-A in patients with coronary artery disease following cardiothoracic surgery. Eur Heart J 2002; 23: 953–959, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Luo Z, Diaco M, Murohara T, Ferrara N, Isner J M, Symes J F. Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thorac Surg 1997; 64: 993–998, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bouloumie A, Schini-Kerth V B, Busse R. Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardiovasc Res 1999; 41: 773–780, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Askari A T, Unzek S, Popovic Z B, Goldman C K, Forudi F, Kiedrowski M, Rovner A, Ellis S G, Thomas J D, DiCorleto P E, Topol E J, Penn M S. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362: 697–703, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Paul S A, Simons J W, Mabjeesh N J. HIF at the crossroads between ischemia and carcinogenesis. J Cell Physiol 2004; 200: 20–30, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kim C H, Cho Y S, Chun Y S, Park J W, Kim M S. Early expression of myocardial HIF-1α in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3–kinase signaling pathway. Circ Res 2002; 90: E25–E33, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]